Anqi Da
ABSTRACT
Cancer therapy is an attractive research field in basic and clinical studies. Among them, nano-based antitumor drugs and delivery systems play increasingly crucial role in tumor treatment, while they are still faced with complicated surrounding environments. Therefore, this review summarized the tumor micro-environments and some nano-based delivery systems including some FDA-approved nano-drugs for clinical use, in addition, the tumor microenvironment sensitive drug delivery systems are also illustrated.
- Pyle C J, Uwadiae F I, Swieboda D P and Harker J A. (2017) Early IL-6 signalling promotes IL-27 dependent maturation of regulatory T cells in the lungs and resolution of viral immunopathology. PLoS pathogens, 13: e1006640.Google Scholar
- Thompson D, Morrice N, Grant L, Le Sommer S, Ziegler K, Whitfield P, Mody N, Wilson H and Delibegović M. (2017) Myeloid protein tyrosine phosphatase 1B (PTP1B) deficiency protects against atherosclerotic plaque formation in the ApoE−/− mouse model of atherosclerosis with alterations in IL10/AMPKα pathway. Molecular metabolism, 6: 845-853.Google Scholar
- Yamamoto M, Kim M, Imai H, Itakura Y and Ohtsuki G. (2019) Microglia-triggered plasticity of intrinsic excitability modulates psychomotor behaviors in acute cerebellar inflammation. Cell reports, 28: 2923-2938. e8.Google Scholar
- Stanford S M, Muench G R A, Bartok B, Sacchetti C, Kiosses W B, Sharma J, Maestre M F, Bottini M, Mustelin T and Boyle D L. (2016) TGFβ responsive tyrosine phosphatase promotes rheumatoid synovial fibroblast invasiveness. Annals of the rheumatic diseases, 75: 295-302.Google ScholarCross Ref
- Steenbrugge J, Breyne K, Demeyere K, De Wever O, Sanders N N, Van Den Broeck W, Colpaert C, Vermeulen P, Van Laere S and Meyer E. (2018) Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer. Journal of Experimental & Clinical Cancer Research, 37: 1-18.Google ScholarCross Ref
- Sidibe A, Ropraz P, Jemelin S, Emre Y, Poittevin M, Pocard M, Bradfield P F and Imhof B A. (2018) Angiogenic factor-driven inflammation promotes extravasation of human proangiogenic monocytes to tumours. Nature communications, 9: 1-19.Google Scholar
- Ryu Y S, Kang K A, Piao M J, Ahn M J, Yi J M, Hyun Y-M, Kim S H, Ko M K, Park C O and Hyun J W. (2019) Particulate matter induces inflammatory cytokine production via activation of NFκB by TLR5-NOX4-ROS signaling in human skin keratinocyte and mouse skin. Redox biology, 21: 101080.Google Scholar
- Eissmann M F, Dijkstra C, Jarnicki A, Phesse T, Brunnberg J, Poh A R, Etemadi N, Tsantikos E, Thiem S and Huntington N D. (2019) IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization. Nature communications, 10: 1-16.Google Scholar
- Passey S L, Bozinovski S, Vlahos R, Anderson G P and Hansen M J. (2016) Serum amyloid A induces Toll-like receptor 2-dependent inflammatory cytokine expression and atrophy in C2C12 skeletal muscle myotubes. PloS one, 11.Google Scholar
- Andrés G, Leali D, Mitola S, Coltrini D, Camozzi M, Corsini M, Belleri M, Hirsch E, Schwendener R A and Christofori G. (2009) A pro‐inflammatory signature mediates FGF2‐induced angiogenesis. Journal of cellular and molecular medicine, 13: 2083-2108.Google ScholarCross Ref
- Abyaneh H S, Regenold M, McKee T D, Allen C and Gauthier M A. (2020) Towards extracellular matrix normalization for improved treatment of solid tumors. Theranostics, 10: 1960.Google ScholarCross Ref
- Rieger H, Fredrich T and Welter M. (2016) Physics of the tumor vasculature: Theory and experiment. The European Physical Journal Plus, 131: 1-24.Google ScholarCross Ref
- Gerweck L E and Seetharaman K. (1996) Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer research, 56: 1194-1198.Google Scholar
- Tian L and Bae Y H. (2012) Cancer nanomedicines targeting tumor extracellular pH. Colloids and Surfaces B: Biointerfaces, 99: 116-126.Google ScholarCross Ref
- Hockel M and Vaupel P. (2001) Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. Journal of the National Cancer Institute, 93: 266-276.Google ScholarCross Ref
- Zhou J, Schmid T, Schnitzer S and Brüne B. (2006) Tumor hypoxia and cancer progression. Cancer letters, 237: 10-21.Google Scholar
- Martin M D and Matrisian L M. (2007) The other side of MMPs: protective roles in tumor progression. Cancer and Metastasis Reviews, 26: 717.Google ScholarCross Ref
- Ventola C L. (2017) Progress in nanomedicine: approved and investigational nanodrugs. Pharmacy and Therapeutics, 42: 742.Google Scholar
- Mizutani H, Tada-Oikawa S, Hiraku Y, Kojima M and Kawanishi S. (2005) Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide. Life sciences, 76: 1439-1453.Google Scholar
- Barenholz Y C. (2012) Doxil®—the first FDA-approved nano-drug: lessons learned. Journal of controlled release, 160: 117-134.Google ScholarCross Ref
- Desai N, Trieu V, Yao Z, Louie L, Ci S, Yang A, Tao C, De T, Beals B and Dykes D. (2006) Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Clinical cancer research, 12: 1317-1324.Google Scholar
- Miele E, Spinelli G P, Miele E, Tomao F and Tomao S. (2009) Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer. International journal of nanomedicine, 4: 99.Google Scholar
- Liang K, Richardson J J, Ejima H, Such G K, Cui J and Caruso F. (2014) Peptide‐Tunable Drug Cytotoxicity via One‐Step Assembled Polymer Nanoparticles. Advanced Materials, 26: 2398-2402.Google ScholarCross Ref
- Zhu L, Wang T, Perche F, Taigind A and Torchilin V P. (2013) Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety. Proceedings of the National Academy of Sciences, 110: 17047-17052.Google ScholarCross Ref
Recommendations
Applications of Nanomaterials in Combined Antitumor Therapy
ICBBS '20: Proceedings of the 2020 9th International Conference on Bioinformatics and Biomedical ScienceCancer has historically been a significant problem in the world. Traditional clinical strategies for treating tumors including chemotherapy, radiation therapy, surgery. Currently, some novel anti-cancer therapeutics such as immunotherapy, photodynamic ...
Deep learning-based tumor microenvironment analysis in colon adenocarcinoma histopathological whole-slide images
Highlights- Use the convolutional neural network to process colon adenocarcinoma whole-slide images.
Abstract Background and Objective: Colon cancer is a fatal disease, and a comprehensive understanding of the tumor microenvironment (TME) could lead to better risk stratification, prognosis prediction, and therapy management. In ...
CD93 orchestrates the tumor microenvironment and predicts the molecular subtype and therapy response of bladder cancer
Abstract BackgroundCD93 is newly reported to normalize vasculature and attenuate pancreatic cancer therapy response, but its role in bladder cancer (BLCA) is unknown.
MethodThe immunologic role of CD93 is analyzed across TCGA pan-cancers. The ...
Highlights- In BLCA, CD93 is indicative of more aggressive clinical features, worse survival, less recognition and killing of cancer cells by T cells, molecular subtypes, lower chemotherapy response and lower immunotherapy response, which is further ...
Comments